Headline News

 

Final Approval from the USFDA for Acyclovir Ointment Received by Zydus

Posted on March 19, 2019

First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of Farxiga in Type-2 Diabetes

Posted on March 19, 2019

To Examine Long-Term Effects Of Repatha® (evolocumab) Amgen Announces New Four-Year Outcomes Study

Posted on March 19, 2019

Novo Nordisk settles US patent litigation case on Victoza® (liraglutide) with Teva

Posted on March 19, 2019

Roche Announces FDA Approval for Tecentriq in Combination with Chemotherapy

Posted on March 19, 2019

Definitive Agreement to Acquire AYUMI Pharmaceutical Signed by Blackstone

Posted on March 19, 2019

C2 PHARMA Acquires Digoxin API Portfolio from Nobilus Ent to Guarantee Long-Term Quality and Supply Chain Security

Posted on March 19, 2019

Pfizer Announces FDA Approval for Oncology Biosimilar Trazimera

Posted on March 18, 2019

Pall Corporation and ARTeSYN Biosolutions Collaboration Agreement Expanded to Accelerate Single-Use Technology Industrialization

Posted on March 14, 2019

Suven Life Sciences Announces the Asset Purchase Agreement of Rising Pharmaceuticals Through its Joint Venture Partner, Shore Suven Pharma Inc.

Posted on March 12, 2019

Roche’s VENTANA PD-L1 (SP142) Assay Approved as First Companion Diagnostic to Identify Triple-Negative Breast Cancer Patients Eligible for Treatment with Tecentriq in Combination with Abraxane

Posted on March 12, 2019

Two USFDA Approvals Recieved by Laurus Labs

Posted on March 12, 2019

EMA Validates Application for BAVENCIO® (AVELUMAB) Plus INLYTA® (AXITINIB) for the Treatment of Advanced Renal Cell Carcinoma

Posted on March 12, 2019

Regeneron announce FDA Approval for DUPIXENT® (DUPILUMAB) Moderate-To-Severe Atopic Dermatitis in Adolescents

Posted on March 12, 2019

Regeneron and GSK Make New Genetic Data on 50,000 UK BioBank Participants Available to Global Health Research Community

Posted on March 12, 2019